Summit Pharmaceutical International’s History

Summit Pharmaceuticals International Corporation

2021Expanded the API Laboratory
2021Acquired 100% shares of Summit Pharmaceuticals China
2020Acquired 100% shares of Summit Pharmaceuticals Europe
2011Changed the name of the Yokohama Laboratory to the Yokohama Support Center
2009Established the API Laboratory in Takatsu-ku, Kawasaki City
2006Summit Medi-Chem merged with Summit Pharmaceuticals International Corporation and inherited its name

Summit Medi-Chem (former name)

2003 Became a wholly owned business investment company of SC
2003 Changed the company name to Summit Medi-Chem
1993 SC invested in Goei Shoji
1949 Goei Shoji was established Started selling industrial chemicals and medical products

Summit Pharmaceuticals International Corporation (former name)

2006 Took over business rights concerning marketing and development of physicochemical devices from SC Bioscience Corporation Established the Yokohama Laboratory in Tsurumi-ku, Yokohama City
1995 Took over the business rights and assets from the New Drugs and Bioscience Department of SC and changed the company name to Summit Pharmaceuticals International Corporation
1985 Sumisho Pharma Corporation was established as a wholly-owned business investment company of Sumitomo Corporation (SC) Started supporting the New Drugs and Bioscience Department of SC, engaged in drug discovery research support, pharmaceuticals and diagnostics licensing, and other supportive activities